Rituximab in the Treatment of Refractory Myasthenia Gravis: Studying the Outcomes Using MMT Score And Need for Plasmapheresis in Baghdad Teaching Hospital. Indian Journal of Forensic Medicine & Toxicology [Internet]. 2020 Apr. 29 [cited 2026 May 22];14(2):2505-10. Available from: https://medicopublication.com/index.php/ijfmt/article/view/3485